Cobra Biologics Appoints CSO
Cobra announces the appointment of Dr. Daniel C. Smith as Chief Scientific Officer
Cobra Biologics is pleased to announce the appointment of Daniel Smith as its Chief Scientific Officer with the responsibility for developing the highest level of scientific excellence across the Group and enhancing Cobra’s DNA, virus, microbial and mammalian proteins research and development platforms. Daniel has spent the last 4 years with the bioProcessUK team at the HealthTech & Medicines Knowledge Transfer Network (KTN), driving the